Clinical Trial Update: A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for a potential new medicine (NNC4005-0001) under development by Novo Nordisk to treat fatty liver disease in adults with overwe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• NNC4005-0001

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Fatty Liver Disease | Phase 1 | Status: RECRUITING